Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries.

MLA

Reijman, M.Doortje, et al. “Cardiovascular Outcomes in Patients with Homozygous Familial Hypercholesterolaemia on Lipoprotein Apheresis Initiated during Childhood: Long-Term Follow-up of an International Cohort from Two Registries.” The Lancet. Child & Adolescent Health, vol. 8, no. 7, July 2024, pp. 491–99. EBSCOhost, https://doi.org/10.1016/S2352-4642(24)00073-7.

APA

Reijman, M. D., Tromp, T. R., Hutten, B. A., Hovingh, G. K., Blom, D. J., Catapano, A. L., Cuchel, M., Dann, E. J., Gallo, A., Hudgins, L. C., Raal, F. J., Ray, K. K., Sadiq, F., Soran, H., Groothoff, J. W., Wiegman, A., & Kusters, D. M. (2024). Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries. The Lancet. Child & Adolescent Health, 8(7), 491–499. https://doi.org/10.1016/S2352-4642(24)00073-7

Chicago

Reijman, M Doortje, Tycho R Tromp, Barbara A Hutten, G Kees Hovingh, Dirk J Blom, Alberico L Catapano, Marina Cuchel, et al. 2024. “Cardiovascular Outcomes in Patients with Homozygous Familial Hypercholesterolaemia on Lipoprotein Apheresis Initiated during Childhood: Long-Term Follow-up of an International Cohort from Two Registries.” The Lancet. Child & Adolescent Health 8 (7): 491–99. doi:10.1016/S2352-4642(24)00073-7.